249 related articles for article (PubMed ID: 18227709)
1. Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit.
Constantinidou A; Hofman M; O'Doherty M; Acland KM; Healy C; Harries M
Melanoma Res; 2008 Feb; 18(1):56-60. PubMed ID: 18227709
[TBL] [Abstract][Full Text] [Related]
2. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.
Baker JJ; Meyers MO; Frank J; Amos KD; Stitzenberg KB; Ollila DW
Am J Surg; 2014 Apr; 207(4):549-54. PubMed ID: 24674829
[TBL] [Abstract][Full Text] [Related]
3. Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy.
Horn J; Lock-Andersen J; Sjøstrand H; Loft A
Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):887-92. PubMed ID: 16586078
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy.
Wagner JD; Schauwecker D; Davidson D; Coleman JJ; Saxman S; Hutchins G; Love C; Hayes JT
J Clin Oncol; 1999 May; 17(5):1508-15. PubMed ID: 10334538
[TBL] [Abstract][Full Text] [Related]
5. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
[TBL] [Abstract][Full Text] [Related]
6. [PET scanning for malignant melanoma and positive sentinel node diagnostics].
Horn J; Sjøstrand H; Lock-Andersen J; Loft A
Ugeskr Laeger; 2010 Apr; 172(15):1126-30. PubMed ID: 20427004
[TBL] [Abstract][Full Text] [Related]
7. Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma.
Singh B; Ezziddin S; Palmedo H; Reinhardt M; Strunk H; Tüting T; Biersack HJ; Ahmadzadehfar H
Melanoma Res; 2008 Oct; 18(5):346-52. PubMed ID: 18781133
[TBL] [Abstract][Full Text] [Related]
8. F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
Maubec E; Lumbroso J; Masson F; Suciu V; Kolb F; Mamelle G; Cavalcanti A; Boitier F; Spatz A; Aupérin A; Leboulleux S; Avril MF
Melanoma Res; 2007 Jun; 17(3):147-54. PubMed ID: 17505260
[TBL] [Abstract][Full Text] [Related]
9. Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
Wagner T; Meyer N; Zerdoud S; Julian A; Chevreau C; Payoux P; Courbon F
Br J Dermatol; 2011 Jun; 164(6):1235-40. PubMed ID: 21332457
[TBL] [Abstract][Full Text] [Related]
10. Initial staging of malignant melanoma by positron emission tomography and sentinel node biopsy.
Libberecht K; Husada G; Peeters T; Michiels P; Gys T; Molderez C
Acta Chir Belg; 2005; 105(6):621-5. PubMed ID: 16438072
[TBL] [Abstract][Full Text] [Related]
11. Baseline staging in cutaneous malignant melanoma.
Hafner J; Schmid MH; Kempf W; Burg G; Künzi W; Meuli-Simmen C; Neff P; Meyer V; Mihic D; Garzoli E; Jungius KP; Seifert B; Dummer R; Steinert H
Br J Dermatol; 2004 Apr; 150(4):677-86. PubMed ID: 15099363
[TBL] [Abstract][Full Text] [Related]
12. The role of preoperative positron emission tomography/computed tomography (PET/CT) in patients with high-risk melanoma.
Barsky M; Cherkassky L; Vezeridis M; Miner TJ
J Surg Oncol; 2014 Jun; 109(7):726-9. PubMed ID: 24375280
[TBL] [Abstract][Full Text] [Related]
13. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
Clark PB; Soo V; Kraas J; Shen P; Levine EA
Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694
[TBL] [Abstract][Full Text] [Related]
14. The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence.
Abbott RA; Acland KM; Harries M; O'Doherty M
Melanoma Res; 2011 Oct; 21(5):446-9. PubMed ID: 21849913
[TBL] [Abstract][Full Text] [Related]
15. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma.
Acland KM; Healy C; Calonje E; O'Doherty M; Nunan T; Page C; Higgins E; Russell-Jones R
J Clin Oncol; 2001 May; 19(10):2674-8. PubMed ID: 11352959
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II.
Fink AM; Holle-Robatsch S; Herzog N; Mirzaei S; Rappersberger K; Lilgenau N; Jurecka W; Steiner A
Melanoma Res; 2004 Apr; 14(2):141-5. PubMed ID: 15057045
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of extensive initial staging procedure in intermediate/high-risk melanoma patients.
Vereecken P; Laporte M; Petein M; Steels E; Heenen M
J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):66-73. PubMed ID: 15649194
[TBL] [Abstract][Full Text] [Related]
18. Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma.
Havenga K; Cobben DC; Oyen WJ; Nienhuijs S; Hoekstra HJ; Ruers TJ; Wobbes T
Eur J Surg Oncol; 2003 Oct; 29(8):662-4. PubMed ID: 14511614
[TBL] [Abstract][Full Text] [Related]
19. PET CT imaging in patients undergoing sentinel node biopsy for melanoma.
Kell MR; Ridge JA; Joseph N; Sigurdson ER
Eur J Surg Oncol; 2007 Sep; 33(7):911-3. PubMed ID: 17207956
[TBL] [Abstract][Full Text] [Related]
20. Desmoplastic malignant melanoma evaluated with 18F-fluorodeoxyglucose positron emission tomography-computed tomography and sentinel lymph node biopsy.
Jung JY; Roh MR; Chung HJ; Chung KY
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):126-7. PubMed ID: 18181996
[No Abstract] [Full Text] [Related]
[Next] [New Search]